Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPV-Al SSI Booster in Infants
NCT03671616Phase 3Completed
- Sponsor
- Statens Serum Institut
- Start
- May 2018
- Primary completion
- Oct 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Picovax in poliomyelitis, sponsored by Statens Serum Institut. Started May 2018; status: completed.
02
Drugs
Picovax
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03671616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03671616.